Skip to main content

Table 3 Group differences in lapse to substance use during the 6-month follow-up (survival analysis)

From: The outcome of integrated motivational interviewing and cognitive-behavioral therapy in Egyptian patients with substance use disorder

 

B (SE)

P

HR (95.0% CI for HR)

Mode of treatment

-2.46 (.60)

< .001**

.08 (.026–.27)

Age

-.037 (.10)

.729

.96 (.78–1.19)

Employment

-.67 (1.03)

.516

.51 (.067–3.89)

ASI medical

-.02 (.27)

.925

.97 (.57–1.66)

ASI employment

.02 (.21)

.919

1.02 (.66–1.57)

ASI drugs

.15 (.36)

.673

1.16 (.57–2.36)

ASI family

.26 (.21)

.217

1.30 (.85–1.97)

ASI legal

.27 (.266)

.300

1.31 (.78–2.22)

Lifetime weeks

.001(.004)

.809

1.001(.99–1.008)

Age onset

.07 (.10)

.490

1.07 (.87–1.31)

Personality disorder

-.32 (.81)

.693

.72 (.14–3.55)

Educated

-.57 (.68)

.402

.56 (.14–2.15)

Married

-2.76 (.76)

< .001**

.06 (.014–.28)

Divorced

2.08 (.93)

.026*

8.06 (1.28–50.74)

  1. B, The regression coefficients predict the hazard of relapse. A positive coefficient indicates a positive relationship between the covariate and the hazard for the relapse (higher values on the covariates are associated with less survival time). A negative coefficient indicates a negative relationship between the covariate and the hazard for the terminal event. Higher values on the covariate are associated with longer survival time. HR hazard ratio. Hazard ratios less than 1 are associated with negative regression slopes, whereas values greater than 1 are associated with positive slopes. A hazard ratio of 1 indicates no change in the hazard per unit change on the covariate
  2. *Significant P value (< .05)
  3. **Highly significant P value (< .001)